Search Site

Trends banner

Eni profit falls due to dip in oil prices

Q2 net profit fell by 18% to $637 million.

Emirates NBD H1 profit $3.40bn

Total income rose by 12 percent in the same period.

ADIB H1 pre-tax profit $1.08bn

Q2 pre-tax net profit increases by 14 percent.

AstraZeneca to invest $50bn in US

Bulk of funds to go into a Virginia manufacturing center.

UAB net profit up by 50% for H1

Total assets increase by 11 percent.

Al-Dawaa raises $27bn in IPO

An Al-Dawaa pharmacy store in Saudi Arabia.
  • With the order book 53.8 times oversubscribed, the final offer price has been set at SR73 per share, according to a bourse filing
  • Individual subscriptions will be invited between Feb. 27 and March 1, offering a maximum of 2.55 million shares

Al-Dawaa, Saudi pharmacy chain, has raised $27 billion in equity from institutional investors after its first sale of shares to the public.

With the order book 53.8 times oversubscribed, the final offer price has been set at SR73 per share, according to a bourse filing.

This translates into a market value of as much as $1.6 billion, the pharma chain operator said in a statement.

Individual subscriptions will be invited between Feb. 27 and March 1, offering a maximum of 2.55 million shares.

“Following a successful book-building process which saw strong demand from institutional investors, the final offer price is testament to the strength of our investment proposition,” said the company’s CEO, Mohammed Al-Farraj.

Listing represents a chance to “strengthen Al-Dawaa’s brand presence and future growth potential as well as reinforce our commitment to the highest standards of corporate governance,” Al-Dawaa commercial director, Fahad Al-Farraj, told Arab News earlier.

Proceeds from the offering will be used to feed that strategy and enhance automation across the company’s supply chain, he said.